Pheochromocytoma and medullary thyroid carcinoma:: A new genotype-phenotype correlation of the RET protooncogene 891 germline mutation

被引：27

作者：

Jimenez, C

Habra, MA

Huang, SCE

El-Naggar, A

Shapiro, SE

Evans, DB

Cote, G

Gagel, RF

机构：

[1] Univ Texas, MD Anderson Canc Ctr, Dept Endocrine Neoplasia & Hormonal Disorders, Houston, TX 77030 USA

[2] Univ Texas, MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA

[3] Univ Texas, MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA

来源：

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM | 2004年 / 89卷 / 08期

关键词：

D O I：

10.1210/jc.2004-0041

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Prior experience in kindreds with a codon 891 RET proto oncogene mutation indicates that carriers of this mutation develop only hereditary medullary thyroid carcinoma without evidence of other manifestations of multiple endocrine neoplasia type 2. In this paper, we report the first documented case in which medullary thyroid carcinoma and pheochromocytoma were clinically expressed in members of a family affected by the codon 891 RET mutation. Genetic analysis of the RET protooncogene in this family revealed an exon 15 missense mutation at codon 891 that resulted in a serine to alanine amino acid substitution. These findings indicate that patients with this mutation should be screened for pheochromocytoma.

引用

页码：4142 / 4145

页数：4

共 31 条

[1] Guidelines for diagnosis and therapy of MEN type 1 and type 2 [J].

Brandi, ML ;

Gagel, RF ;

Angeli, A ;

Bilezikian, JP ;

Beck-Peccoz, P ;

Bordi, C ;

Conte-Devolx, B ;

Falchetti, A ;

Gheri, RG ;

Libroia, A ;

Lips, CJM ;

Lombardi, G ;

Mannelli, M ;

Pacini, F ;

Pondder, BAJ ;

Raue, F ;

Skogseid, B ;

Tamburrano, G ;

Thakker, RV ;

Thompson, NW ;

Tomassetti, P ;

Tonelli, F ;

Wells, SA ;

Marx, SJ .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (12) :5658-5671

[2] GFRα1 is an essential receptor component for GDNF in the developing nervous system and kidney [J].

Cacalano, G ;

Fariñas, I ;

Wang, LC ;

Hagler, K ;

Forgie, A ;

Moore, M ;

Armanini, M ;

Phillips, H ;

Ryan, AM ;

Reichardt, LF ;

Hynes, M ;

Davies, A ;

Rosenthal, A .

NEURON, 1998, 21 (01) :53-62

[3]

Carlomagno F, 1997, CANCER RES, V57, P391

[4] SINGLE MISSENSE MUTATION IN THE TYROSINE KINASE CATALYTIC DOMAIN OF THE RET PROTOONCOGENE IS ASSOCIATED WITH MULTIPLE ENDOCRINE NEOPLASIA TYPE 2B [J].

CARLSON, KM ;

DOU, SS ;

CHI, D ;

SCAVARDA, N ;

TOSHIMA, K ;

JACKSON, CE ;

WELLS, SA ;

GOODFELLOW, PJ ;

DONISKELLER, H .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (04) :1579-1583

[5] A novel germ-line point mutation in RET exon 8 (Gly533Cys) in a large kindred with familial medullary thyroid carcinoma [J].

Da Silva, AMA ;

Maciel, RMB ;

Da Silva, MRD ;

Toledo, SRC ;

De Carvalho, MB ;

Cerutti, JM .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (11) :5438-5443

[6] A codon 891 exon 15 RET proto-oncogene mutation in familial medullary thyroid carcinoma:: a detection strategy [J].

Dang, GT ;

Cote, GJ ;

Schultz, PN ;

Khorana, S ;

Decker, RA ;

Gagel, RF .

MOLECULAR AND CELLULAR PROBES, 1999, 13 (01) :77-79

[7] MUTATIONS IN THE RET PROTOONCOGENE ARE ASSOCIATED WITH MEN 2A AND FMTC [J].

DONISKELLER, H ;

DOU, SS ;

CHI, D ;

CARLSON, KM ;

TOSHIMA, K ;

LAIRMORE, TC ;

HOWE, JR ;

MOLEY, JF ;

GOODFELLOW, P ;

WELLS, SA .

HUMAN MOLECULAR GENETICS, 1993, 2 (07) :851-856

[8] GDNF signalling through the Ret receptor tyrosine kinase [J].

Durbec, P ;

MarcosGutierrez, CV ;

Kilkenny, C ;

Grigoriou, M ;

Wartiovaara, K ;

Suvanto, P ;

Smith, D ;

Ponder, B ;

Costantini, F ;

Saarma, M ;

Sariola, H ;

Pachnis, V .

NATURE, 1996, 381 (6585) :789-793

[9] The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2 - International RET mutation consortium analysis [J].

Eng, C ;

Clayton, D ;

Schuffenecker, I ;

Lenoir, G ;

Cote, G ;

Gagel, RF ;

vanAmstel, HKP ;

Lips, CJM ;

Nishisho, I ;

Takai, SI ;

Marsh, DJ ;

Robinson, BG ;

FrankRaue, K ;

Raue, F ;

Xue, FY ;

Noll, WW ;

Romei, C ;

Pacini, F ;

Fink, M ;

Niederle, B ;

Zedenius, J ;

Nordenskjold, M ;

Komminoth, P ;

Hendy, GN ;

Gharib, H ;

Thibodeau, SN ;

Lacroix, A ;

Frilling, A ;

Ponder, BAJ ;

Mulligan, LM .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (19) :1575-1579

[10] FAMILIAL MEDULLARY-THYROID CARCINOMA WITHOUT ASSOCIATED ENDOCRINOPATHIES - A DISTINCT CLINICAL ENTITY [J].

FARNDON, JR ;

LEIGHT, GS ;

DILLEY, WG ;

BAYLIN, SB ;

SMALLRIDGE, RC ;

HARRISON, TS ;

WELLS, SA .

BRITISH JOURNAL OF SURGERY, 1986, 73 (04) :278-281

← 1 2 3 4 →